These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 3547606)

  • 21. [Central venous injection of large amounts of contrast media--advantages of a low osmolar contrast medium in experimentally-induced pulmonary hypertension].
    Schräder R; Wolpers HG; Korb H; Hoeft A; Klepzig H; Kober G; Hellige G
    Z Kardiol; 1984 Jul; 73(7):434-41. PubMed ID: 6485470
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Acute cardiac side effects of iodecol, a new nonionic dimer roentgen contrast medium, in intracoronary injection].
    Schräder R; Hoeft A; Hoeft T; Korb H; Wolpers HG; Kober G; Hellige G
    Z Kardiol; 1985 Oct; 74(10):604-10. PubMed ID: 4072332
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contrast medium use.
    Davidson C; Stacul F; McCullough PA; Tumlin J; Adam A; Lameire N; Becker CR;
    Am J Cardiol; 2006 Sep; 98(6A):42K-58K. PubMed ID: 16949380
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Risk of application of contrast medium in computed tomography (author's transl)].
    Wende S; Speck U
    Radiologe; 1981 Jun; 21(6):268-73. PubMed ID: 7022551
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Contrast media-associated nephrotoxicity.
    Rudnick MR; Berns JS; Cohen RM; Goldfarb S
    Semin Nephrol; 1997 Jan; 17(1):15-26. PubMed ID: 9000546
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Are nonionic contrast media identical in their tolerability? Results of a double-blind randomized multicenter study with iomeprol and iopromide].
    Schmiedel E
    Aktuelle Radiol; 1997 Jul; 7(4):183-8. PubMed ID: 9340014
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The possibility of side effects during the application of roentgenologic contrast media by the method of the biphasic bolus/perfusor injection and the monophasic bolus injection (author's transl)].
    Kirschner H; Kremp A; Poppe H
    Rofo; 1980 Aug; 133(2):119-24. PubMed ID: 6449424
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Prospective study of adverse reactions to contrast media administered intravenously--a comparison of low-osmolality and high-osmolality contrast media].
    Higashi S; Takizawa K; Suzuki S; Nagashima J; Tamura S; Ishikawa M; Obuchi M; Katayama M
    Nihon Igaku Hoshasen Gakkai Zasshi; 1988 Nov; 48(11):1364-70. PubMed ID: 3237463
    [No Abstract]   [Full Text] [Related]  

  • 29. [Contrast media and percutaneous coronary interventions].
    Aubry P; Halna du Fretay X; Tchetche D
    Ann Cardiol Angeiol (Paris); 2007 Jan; 56(1):2-9. PubMed ID: 17343032
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Angiographic contrast agents: conventional and new media compared.
    Bettmann MA
    AJR Am J Roentgenol; 1982 Oct; 139(4):787-94. PubMed ID: 6812399
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Side effects from angiographic contrast media. Subjective, objective, instrumental and laboratorial.
    Cittadini G; Mallarini G; Roccatagliata C; Zattoni J
    Radiol Med; 1986 Jun; 72(6 Suppl 1):14-9. PubMed ID: 3523637
    [No Abstract]   [Full Text] [Related]  

  • 32. New Media. Pharmacology of nonionic dimers.
    Speck U; Mutzel W; Mannesmann G; Pfeiffer H; Siefert HM
    Invest Radiol; 1980; 15(6 Suppl):S317-22. PubMed ID: 7203942
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A short survey on experimental studies with relevance to vascular use of metrizamide.
    Almén T
    Diagn Imaging; 1979; 48(4):185-90. PubMed ID: 498907
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effect of intravenous contrast media used in urography on the complement system and blood calcium].
    Korzec-Grzegorczyk I
    Pol Tyg Lek; 1989 May 1-8; 44(18-19):423-6. PubMed ID: 2636987
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adverse reactions to ionic and nonionic contrast media. A report from the Japanese Committee on the Safety of Contrast Media.
    Katayama H; Yamaguchi K; Kozuka T; Takashima T; Seez P; Matsuura K
    Radiology; 1990 Jun; 175(3):621-8. PubMed ID: 2343107
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The adverse effects of angiographic radiocontrast media.
    Westhoff-Bleck M; Bleck JS; Jost S
    Drug Saf; 1991; 6(1):28-36. PubMed ID: 2029351
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Selective use of low osmolality contrast agents: cost and benefits.
    Ohnesorgen EG; Yoshino MT
    Radiol Technol; 1988; 59(6):499-502. PubMed ID: 3136507
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Difficulties of risk determination from the use of new contrast media.
    Vogel H; Ludwig A
    Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():2-5. PubMed ID: 2568794
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nonionic contrast use in cardiac angiography.
    Hill JA
    Invest Radiol; 1993 Nov; 28 Suppl 5():S48-53; discussion S54. PubMed ID: 8282503
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Osmolality of contrast media--a risk factor in radiological endovascular procedures in children].
    Mikhel'son BA; Guliev ND; Lazarev VV; Poliaev IuA; Vodolazov IuA
    Khirurgiia (Mosk); 1991 Aug; (8):85-9. PubMed ID: 1942890
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.